Dynamic Wealth Strategies’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8K Hold
40
﹤0.01% 278
2026
Q1
$2.03K Hold
40
﹤0.01% 270
2025
Q4
$1.18K Hold
40
﹤0.01% 244
2025
Q3
$1.03K Hold
40
﹤0.01% 237
2025
Q2
$1.1K Hold
40
﹤0.01% 229
2025
Q1
$1.13K Buy
+40
New +$1.42K ﹤0.01% 229
2024
Q4
Sell
-40
Closed -$3K 172
2024
Q3
$3K Hold
40
﹤0.01% 219
2024
Q2
$5K Hold
40
﹤0.01% 224
2024
Q1
$4K Hold
40
﹤0.01% 230
2023
Q4
$3.98K Buy
+40
New +$3.36K ﹤0.01% 230

Other funds holding MRNA

Dynamic Wealth Strategies's MRNA Position: Q2 2026 in Review

Dynamic Wealth Strategies held its Moderna (MRNA) position steady in Q2 2026 at 40 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Dynamic Wealth Strategies first reported a position in MRNA in Q4 2023 and has held it in 10 quarters since. The position peaked at $5K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Dynamic Wealth Strategies held 40 shares of Moderna worth $2.8K as of Q2 2026.
  • Dynamic Wealth Strategies left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Dynamic Wealth Strategies's portfolio in Q2 2026, its #278 holding.
  • Dynamic Wealth Strategies first reported a position in Moderna in Q4 2023 and has held it in 10 quarters since.
  • Dynamic Wealth Strategies's Moderna position peaked at $5K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.